Stephen T. Sonis

Inform Genomics, Inc. develops novel platform of personalized medicine products for cancer supportive care and inflammatory diseases. It offers proprietary patented systems architecture, patented machine learning algorithms including learning along with mobile applications to develop genomic-base. The company was founded by Edward B. Rubenstein and Stephen T. Sonis and is headquartered in Boston, MA.

Inform Genomics, Inc. develops novel platform of personalized medicine products for cancer supportive care and inflammatory diseases. It offers proprietary patented systems architecture, patented machine learning algorithms including learning along with mobile applications to develop genomic-base. The company was founded by Edward B. Rubenstein and Stephen T. Sonis and is headquartered in Boston, MA.

Inform Genomics, Inc. develops novel platform of personalized medicine products for cancer supportive care and inflammatory diseases. It offers proprietary patented systems architecture, patented machine learning algorithms including learning along with mobile applications to develop genomic-base. The company was founded by Edward B. Rubenstein and Stephen T. Sonis and is headquartered in Boston, MA.

Inform Genomics, Inc. develops novel platform of personalized medicine products for cancer supportive care and inflammatory diseases. It offers proprietary patented systems architecture, patented machine learning algorithms including learning along with mobile applications to develop genomic-base. The company was founded by Edward B. Rubenstein and Stephen T. Sonis and is headquartered in Boston, MA.

Inform Genomics, Inc. develops novel platform of personalized medicine products for cancer supportive care and inflammatory diseases. It offers proprietary patented systems architecture, patented machine learning algorithms including learning along with mobile applications to develop genomic-base. The company was founded by Edward B. Rubenstein and Stephen T. Sonis and is headquartered in Boston, MA.